期刊
TRANSGENIC RESEARCH
卷 29, 期 3, 页码 339-353出版社
SPRINGER
DOI: 10.1007/s11248-020-00202-1
关键词
Fibrinogen; Bombyx mori; Silk glands; Recombinant proteins; N-glycan
Fibrinogen from human blood is used as a main component of coagulants, including surgical tissue sealants. The development of a recombinant human fibrinogen (rFib) is anticipated to eliminate the risks of blood-borne infections. Here, we report the efficient production of rFib in a transgenic silkworm system. A silkworm line carrying cDNAs of the fibrinogen A alpha and gamma chains (A alpha/gamma-silkworm) produced A alpha and gamma chains in its cocoons, however, the B beta chains were not detected from cocoons of another silkworm line carrying the cDNA of fibrinogen B beta chains (B beta-silkworm). A silkworm line for all three fibrinogen chains was generated by crossing A alpha/gamma-silkworms with B beta-silkworms, which secreted A alpha B-2 beta(2)gamma(2) fibrinogen (rFib) into cocoons at high contents. The N-terminal amino acid sequences of the three rFib chains were identical to those of the corresponding chains of native fibrinogen (nFib). The N-glycan profile of the rFib comprised oligomannose-type (53%), complex-type (34%), and paucimannose-type (13%); neither high-mannose-type (six or more mannose residues) nor core-fucosylated glycans were observed. The coagulation activity of the rFib was evaluated for the amount of thrombin-released fibrinopeptide A (FpA) and the kinetics for turbidity increase (non-covalent network formation) in the solution. FpA release rates were equivalent between rFib and nFib; by contrast, the kinetics of the turbidity increase for rFib were accelerated nearly two-fold, for both the rate and maximum value, compared to those of nFib. These results demonstrate that the rFib produced in the transgenic silkworm system is comparable to nFib in both physical and coagulative properties. This rFib is a promising candidate component for safe hemostatic pharmaceuticals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据